Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...

Crinetics shares PATHFNDR trial data showing oral Palsonify maintained hormone and symptom control in acromegaly patients ...

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATH ...

Over time this may speed up hair thinning especially in those already prone to androgenetic alopecia male or female pattern ...

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...

The level of insulin-like growth factor 1 (IGF-I) is influenced by many factors but, as detailed here, IGF-I measurements are useful to screen for growth hormone deficiencies in children and young ...

Digital participation, freedom of expression and human rights are the focus of the UN World Summit on the Information Society ...

The Palsonify-treated subjects maintained control, with stable growth hormone levels, symptom scores, and pituitary tumour ...

Affiliate content. Uncover the best colostrum supplements of 2025 that support gut health, immune function, and overall ...

Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly gynecologic malignancy often d ...

On the final day of IGF London 2025, spiritual leader and ISKCON monk Gauranga Das delivered a profound address at Taj St. James' Court, urging global leaders and changemakers to reimagine progress ...

We are inviting members to share case studies, expertise and best practice through blogs, vlogs, events, and social media.